Salute e Benessere
Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
: https://www.marknteladvisors.com/query/request-sample/global-vitamin-b12-market.html
The competitive landscape of the global Vitamin B12 market features a strong mix of top Vitamin B12 companies, trusted brands, and leading manufacturers driving innovation and supply worldwide. Key industry players dominating the Vitamin B12 segment include Hebei Yufeng Group, Hebei Huarong Pharmaceutical, BASF Nutrition, Sanofi, NCPC VICTOR, Chempure, Hebei Yuxing Bio-Engineering Co. Ltd, Ningxia Kingvit Pharmaceutical, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., LUPIN, Mylan N.V., Apotex Inc., Bristol Laboratories Ltd., Mankind Pharma, and Biocon, among others. These companies are recognized for their large-scale production capacities, high-quality formulations, and extensive distribution networks, making them crucial contributors to the growth of the global Vitamin B12 market.
: https://www.marknteladvisors.com/research-library/global-vitamin-b12-market.html
is projected to dominate the market due to:
North America and Europe will continue to hold substantial market shares, driven by advanced healthcare infrastructure, preventive medicine adoption, and high supplement penetration rates.
While Vitamin B12 is generally considered safe, excessive intake can cause mild side effects, including skin irritation, headaches, and dizziness in sensitive individuals. Certain medical conditions, such as Leber's hereditary optic neuropathy, require caution. Industry leaders are responding by implementing clear dosage labeling, robust consumer education campaigns, and third-party testing for quality assurance.
A. The market is valued at approximately USD 288 million in 2024 and is projected to reach USD 444.47 million by 2030, growing at a CAGR of around 7.50%.
A. Major players include Hebei Yufeng Group, BASF Nutrition, Sanofi, Merck & Co., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., and Mankind Pharma among others.
A. Key sectors include pharmaceuticals, nutraceuticals, food & beverage, feed supplements, and cosmetics.
A. Rising veganism, increasing vitamin deficiencies, and higher health awareness are driving global demand.
A. Supports blood health, DNA synthesis, nerve function, and helps prevent megaloblastic anemia.
A. Asia-Pacific dominates due to high deficiency rates, rising incomes, and growing vegan/vegetarian populations.
A. offers in-depth Vitamin B12 market analysis with forecasts, segmentation, and competitive intelligence to help businesses make data-driven decisions.
A. Investors can explore partnerships with leading manufacturers, nutraceutical startups, or distribution networks to capitalize on the growing demand.
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific , Europe , the Middle East & Africa , etc., and many countries across the regional scale, namely, the US, India , the Netherlands , Saudi Arabia , the UAE, Brazil , and several others.
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301,
India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
https://www.marknteladvisors.com
https://www.marknteladvisors.com/press-release/global-vitamin-b12-market-growth
Logo: https://mma.prnewswire.com/media/2687299/MarkNtel_Advisors_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/vitamin-b12-market-set-to-surpass-usd-444-47-million-by-2030--driven-by-rising-veganism-preventive-healthcare-focus-and-growth-in-nutraceuticals-markntel-advisors-302529951.html